Distress Associated With Stopping Immunotherapy of Cancer Patients
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Reduce fear of recurrence
研究概览
简要总结
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
详细描述
The intervention will be delivered through telemedicine to reduce the patient-related barriers to treatment including cost, transportation, and being able to maintain appointments while managing the side effects of treatment. The intervention will provide the patient with skills to reduce distress associated with ceasing treatment of a checkpoint inhibitor through the development evidence-based psychological and behavioral strategies that are tailored to the patients' preferences.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 21 years and older
- •Fluent in English
- •Diagnosis of cancer and history of treatment with immunotherapy
排除标准
- •Active suicidal ideation, delusions or hallucinations
结局指标
主要结局
Reduce fear of recurrence
时间窗: 3 months
Change by 50%
次要结局
- Improve quality of life(3 months)
- Depressive symptoms(3 months)
- Reduction of anxiety(3 months)
研究者
Jennifer Steel
Professor
University of Pittsburgh